Citations

Clear

6273 citation(s) found for "To, Andrew".

Alzheimer's disease is associated with reduced expression of energy metabolism genes in posterior cingulate neurons
Liang, Winnie S. , Reiman, Eric M. , Valla, Jon, Dunckley, Travis , Beach, Thomas G. , Grover, Andrew, Niedzielko, Tracey L., Schneider, Lonnie , Mastroeni, Diego , Caselli, Richard J. , Kukull, Walter A. , Morris, John C. , Hulette, Christine M., Schmechel, Donald E., Rogers, Joseph, Stephan, Dietrich A. , Morris, John C

Mayo Clinic

Proceedings of the National Academy of Sciences | March 10, 2008 | Volume: 105 | Issue: 11 | Pages: 4441-4446

10.1073/pnas.0709259105 | PMID 18332434 Get It

Alzheimer's disease (AD) is associated with regional reductions in fluorodeoxyglucose positron emission tomography (FDG PET) measurements of the cerebral metabolic rate for glucose, which may begin long before the onset of histopathological or clinical features, especially in carriers of a common AD susceptibility gene. Molecular evaluation of cells from metabolically affected brain regions could provide new information about the pathogenesis of AD and new targets at which to aim disease-slowing and prevention therapies. Data from a genome-wide transcriptomic study were used to compare the expression of 80 metabolically relevant nuclear genes from laser-capture microdissected non-tangle-bearing neurons from autopsy brains of AD cases and normal controls in posterior cingulate cortex, which is metabolically affected in the earliest stages; other brain regions metabolically affected in PET studies of AD or normal aging; and visual cortex, which is relatively spared. Compared with controls, AD cases had significantly lower expression of 70% of the nuclear genes encoding subunits of the mitochondrial electron transport chain in posterior cingulate cortex, 65% of those in the middle temporal gyrus, 61% of those in hippocampal CA1, 23% of those in entorhinal cortex, 16% of those in visual cortex, and 5% of those in the superior frontal gyrus. Western blots confirmed underexpression of those complex I–V subunits assessed at the protein level. Cerebral metabolic rate for glucose abnormalities in FDG PET studies of AD may be associated with reduced neuronal expression of nuclear genes encoding subunits of the mitochondrial electron transport chain.
A double-blind, randomized study evaluating losartan potassium monotherapy or in combination with hydrochlorothiazide versus placebo in obese patients with hypertension
Oparil, Suzanne , Abate, Nicola , Chen, E., Galet, Vincent A., Jia, Gang , Julius, Stevo, Lerman, A., Lyle, Paulette A., Pool, James L., Tershakovec, Andrew M. , Creager, Mark A.

Mayo Clinic

Current Medical Research and Opinion | March 8, 2008 | Volume: 24 | Issue: 4 | Pages: 1101-1114

10.1185/030079908x280716 | PMID 18328120 Get It

Use of IGHV3–21 in chronic lymphocytic leukemia is associated with high-risk disease and reflects antigen-driven, post–germinal center leukemogenic selection
Jain, Sonia , Widhopf, George F., Rassenti, Laura Z., Keating, Michael J. , Wierda, William G. , Brown, Jennifer R. , Rai, Kanti R., Byrd, John C. , Greaves, Andrew, Byrd, John C. , Ghia, Emanuela M. , Gribben, John G. , Rai, Kanti R., Kay, Neil E. , Kipps, Thomas J. , Byrd, John C

Mayo Clinic

Blood | March 8, 2008 | Volume: 111 | Issue: 10 | Pages: 5101-5108

10.1182/blood-2007-12-130229 | PMID 18326815 Get It

AbstractWe examined the chronic lymphocytic leukemia (CLL) cells of 2457 patients evaluated by the CLL Research Consortium (CRC) and found that 63 (2.6%) expressed immunoglobulin (Ig) encoded by the Ig heavy-chain-variable-region gene (IGHV), IGHV3-21. We identified the amino acid sequence DANGMDV (motif-1) or DPSFYSSSWTLFDY (motif-2) in the Ig heavy-chain (IgH) third complementarity-determining region (HCDR3) of IgH, respectively, used by 25 or 3 cases. The IgH with HCDR3 motif-1 or motif-2, respectively, was paired with Ig light chains (IgL) encoded by IGLV3-21 or IGKV3-20, suggesting that these Ig had been selected for binding to conventional antigen(s). Cases that had HCDR3 motif-1 had a median time from diagnosis to initial therapy comparable with that of cases without a defined HCDR3 motif, as did cases that used mutated IGHV3-21 (n = 27) versus unmutated IGHV3-21 (n = 30). Of 7 examined cases that used Ig encoded by IGHV3-21/IGLV3-21, we found that 5 had a functionally rearranged IGKV allele that apparently had incurred antigendriven somatic mutations and subsequent rearrangement with KDE. This study reveals that CLL cells expressing IGHV3-21/IGLV3-21 most likely were derived from B cells that had experienced somatic mutation and germinal-center maturation in an apparent antigen-driven immune response before undergoing Ig-receptor editing and after germinal-center leukemogenic selection.
Genome Screen to Detect Linkage to Intracranial Aneurysm Susceptibility Genes
Sauerbeck, Laura, Brown, Robert D., Anderson, Craig S. , Woo, Daniel , Kleindorfer, Dawn , Flaherty, Matthew L. , Deka, Ranjan , Hornung, Richard, Meissner, Irene, Bailey‐Wilson, Joan E. , Connolly, E. Sander , Koller, Daniel L., Investigators, the FIA Study, Derdeyn, Colin P. , Hankey, Graeme J. , Ringer, Andrew J. , Tirschwell, David , Ogilvy, Christopher S. , Foroud, Tatiana , Rouleau, Guy Armand , Lai, Dongbing , Huston, John , Broderick, Joseph P. , Investigators, the FIA Study, Wilson, Richard K , Hankey, Graeme J , Ogilvy, Christopher S , Derdeyn, Colin P

Mayo Clinic

Stroke | March 7, 2008 | Volume: 39 | Issue: 5 | Pages: 1434-1440

10.1161/strokeaha.107.502930 | PMID 18323491 Get It

Background and Purpose— Evidence supports a substantial genetic contribution to the risk of intracranial aneurysm (IA). The purpose of this study was to identify chromosomal regions likely to harbor genes that contribute to the risk of IA. Methods— Multiplex families having at least 2 individuals with “definite” or “probable” IA were ascertained through an international consortium. First-degree relatives of individuals with IA who were at increased risk of an IA because of a history of hypertension or present smoking were offered cerebral magnetic resonance angiography. A genome screen was completed using the Illumina 6K SNP system, and the resulting data from 192 families, containing 1155 genotyped individuals, were analyzed. Narrow and broad disease definitions were used when testing for linkage using multipoint model-independent methods. Ordered subset analysis was performed to test for a gene×smoking (pack-years) interaction. Results— The greatest evidence of linkage was found on chromosomes 4 (LOD=2.5; 156 cM), 7 (LOD=1.7; 183 cM), 8 (LOD=1.9; 70 cM), and 12 (LOD=1.6; 102 cM) using the broad disease definition. Using the average pack-years for the affected individuals in each family, the genes on chromosomes 4 (LOD=3.5; P =0.03), 7 (LOD=4.1; P =0.01) and 12 (LOD=3.6; P =0.02) all appear to be modulated by the degree of smoking in the affected members of the family. On chromosome 8, inclusion of smoking as a covariate did not significantly strengthen the linkage evidence, suggesting no interaction between the loci in this region and smoking. Conclusions— We have detected possible evidence of linkage to 4 chromosomal regions. There is potential evidence for a gene×smoking interaction with 3 of the loci.
Clonally related follicular lymphomas and histiocytic/dendritic cell sarcomas: evidence for transdifferentiation of the follicular lymphoma clone
Martı́nez, Antonio , Burke, Jerome S., Raffeld, Mark , Camós, Mireia , Warnke, Roger A., Feldman, Andrew L. , Arber, Daniel A. , Pittaluga, Stefania , Jaffe, Elaine S.

Mayo Clinic

Blood | February 13, 2008 | Volume: 111 | Issue: 12 | Pages: 5433-5439

10.1182/blood-2007-11-124792 | PMID 18272816 Get It

Abstract Rare cases of histiocytic and dendritic cell (H/DC) neoplasms have been reported in patients with follicular lymphoma (FL), but the biologic relationship between the 2 neoplasms is unknown. We studied 8 patients with both FL and H/DC neoplasms using immunohistochemistry, fluorescence in situ hybridization (FISH) for t(14;18), and polymerase chain reaction (PCR)/sequencing of BCL2 and IGH rearrangements. There were 5 men and 3 women (median age, 59 years). All cases of FL were positive for t(14;18). The H/DC tumors included 7 histiocytic sarcomas, 5 of which showed evidence of dendritic differentiation, and 1 interdigitating cell sarcoma. Five H/DC tumors were metachronous, following FL by 2 months to 12 years; tumors were synchronous in 3. All 8 H/DC tumors showed presence of the t(14;18) either by FISH, or in 2 cases by PCR with the major breakpoint region (MBR) probe. PCR and sequencing identified identical IGH gene rearrangements or BCL2 gene breakpoints in all patients tested. All H/DC tumors lacked PAX5, and up-regulation of CEBPβ and PU.1 was seen in all cases tested. These results provide evidence for a common clonal origin of FL and H/DC neoplasms when occurring in the same patient, and suggest that lineage plasticity may occur in mature lymphoid neoplasms.
Altered neuronal gene expression in brain regions differentially affected by Alzheimer's disease: a reference data set
Liang, Winnie S. , Dunckley, Travis , Beach, Thomas G. , Grover, Andrew, Mastroeni, Diego , Ramsey, Keri , Caselli, Richard J. , Kukull, Walter A. , McKeel, Daniel W., Morris, John C. , Hulette, Christine M., Schmechel, Donald E., Reiman, Eric M. , Rogers, Joseph, Stephan, Dietrich A. , Morris, John C

Mayo Clinic

Physiological Genomics | February 12, 2008 | Volume: 33 | Issue: 2 | Pages: 240-256

10.1152/physiolgenomics.00242.2007 | PMID 18270320 Get It

Alzheimer's Disease (AD) is the most widespread form of dementia during the later stages of life. If improved therapeutics are not developed, the prevalence of AD will drastically increase in the coming years as the world's population ages. By identifying differences in neuronal gene expression profiles between healthy elderly persons and individuals diagnosed with AD, we may be able to better understand the molecular mechanisms that drive AD pathogenesis, including the formation of amyloid plaques and neurofibrillary tangles. In this study, we expression profiled histopathologically normal cortical neurons collected with laser capture microdissection (LCM) from six anatomically and functionally discrete postmortem brain regions in 34 AD-afflicted individuals, using Affymetrix Human Genome U133 Plus 2.0 microarrays. These regions include the entorhinal cortex, hippocampus, middle temporal gyrus, posterior cingulate cortex, superior frontal gyrus, and primary visual cortex. This study is predicated on previous parallel research on the postmortem brains of the same six regions in 14 healthy elderly individuals, for which LCM neurons were similarly processed for expression analysis. We identified significant regional differential expression in AD brains compared with control brains including expression changes of genes previously implicated in AD pathogenesis, particularly with regard to tangle and plaque formation. Pinpointing the expression of factors that may play a role in AD pathogenesis provides a foundation for future identification of new targets for improved AD therapeutics. We provide this carefully phenotyped, laser capture microdissected intraindividual brain region expression data set to the community as a public resource.
Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium
Smedby, Karin E. , Vajdic, Claire M. , Falster, Michael O. , Martı́nez-Maza, Otoniel , Turner, Jennifer , Hjalgrim, Henrik , Vineis, Paolo , Costantini, Adele Seniori , Bracci, Paige M. , Holly, Elizabeth A., Willett, Eleanor V., Spinelli, John J., Vecchia, Carlo La , Zheng, Tongzhang, Becker, Nikolaus, Sanjosé, Sílvia de , Maso, Luigino Dal , Cocco, Pierluigi , Foretová, Lenka , Staines, Anthony , Brennan, Paul , Severson, Richard K., Cerhan, James R. , Breen, Elizabeth C. , Birmann, Brenda M. , Grulich, Andrew E. , Kane, Eleanor , Engels, Eric A. , Chiu, Brian C.‐H. , Maynadié, Marc , Davis, Scott , Cozen, Wendy , Cerhan, James R , Turner, Jennifer , Cocco, Pierluigi , Vajdic, Claire M , Kane, Eleanor , Martínez-Maza, Otoniel , Birmann, Brenda M

Mayo Clinic

Blood | February 8, 2008 | Volume: 111 | Issue: 8 | Pages: 4029-4038

10.1182/blood-2007-10-119974 | PMID 18263783 Get It

Abstract Some autoimmune disorders are increasingly recognized as risk factors for non-Hodgkin lymphoma (NHL) overall, but large-scale systematic assessments of risk of NHL subtypes are lacking. We performed a pooled analysis of self-reported autoimmune conditions and risk of NHL and subtypes, including 29 423 participants in 12 case-control studies. We computed pooled odds ratios (OR) and 95% confidence intervals (CI) in a joint fixed-effects model. Sjögren syndrome was associated with a 6.5-fold increased risk of NHL, a 1000-fold increased risk of parotid gland marginal zone lymphoma (OR = 996; 95% CI, 216-4596), and with diffuse large B-cell and follicular lymphomas. Systemic lupus erythematosus was associated with a 2.7-fold increased risk of NHL and with diffuse large B-cell and marginal zone lymphomas. Hemolytic anemia was associated with diffuse large B-cell NHL. T-cell NHL risk was increased for patients with celiac disease and psoriasis. Results for rheumatoid arthritis were heterogeneous between studies. Inflammatory bowel disorders, type 1 diabetes, sarcoidosis, pernicious anemia, and multiple sclerosis were not associated with risk of NHL or subtypes. Thus, specific autoimmune disorders are associated with NHL risk beyond the development of rare NHL subtypes in affected organs. The pattern of associations with NHL subtypes may harbor clues to lymphomagenesis.
Omega-3 polyunsaturated fatty acids (PUFA) for type 2 diabetes mellitus
Hartweg, Janine, Perera, Rafael , Montori, Víctor M. , Dinneen, Seán F. , Neil, Andrew , Farmer, Andrew J, Farmer, Andrew J, Montori, Victor M , Dinneen, Sean F

Mayo Clinic

Cochrane Database of Systematic Reviews | February 6, 2008 | Volume: 2009 | Issue: 1 | Pages: No page available

10.1002/14651858.cd003205.pub2 | PMID 18254017 Get It

Allergic reaction to a bovine dural substitute following spinal cord untethering
Foy, Andrew , Raffel, Corey , Giannini, Caterina

Mayo Clinic

Journal of Neurosurgery: Pediatrics | February 4, 2008 | Volume: 1 | Issue: 2 | Pages: 167-169

10.3171/ped/2008/1/2/167 | PMID 18352792 Get It

✓Bovine tissues are now routinely used for dural closure in cranial and spinal surgery. The authors report the case of an 18-year-old woman with a history of myelomeningocele who had symptoms of tethered cord syndrome and presented to a regional hospital. At that hospital she underwent a cord untethering procedure. The spinal dura was closed with Durepair, a dural substitute derived from fetal bovine skin. Her postoperative course was complicated by a cerebrospinal fluid leak that was surgically repaired. Following this, she developed erythroderma, intermittent fevers, eosinophilia, and marked elevation in serum immunoglobulin E. She was then transferred to the authors' institution. A skin antigen test to beef was administered, which revealed a positive reaction. A radioallergosorbent test to beef also yielded positive results. She was taken to the operating room for removal of the bovine graft due to concern for an allergic reaction to the graft. The graft material showed evidence of eosinophilic infiltration. Her clinical symptoms and laboratory values all improved after surgery. To the authors' knowledge this is the first reported case of an allergic reaction to bovine-based dural substitutes.